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Conclusions: Conventional criteria for accelerator QA have 
been implemented in a practical software tool. Furthermore, 
new concepts like relative flatness, relative symmetry and 
relative depth dose (RDD) as alternative for PDD are also 
available. For FFF-beams gamma analysis may be used to 
compare with baseline profiles. This approach can also be 
used for 2D-arrays. Flexible configuration makes the tool 
compliant with institution policies. 
This tool, BistroMath, (http://bistromath.nl) can handle 
beam measurement data of all major vendors, automatically 
comparing data with stored reference data with a flexible 
and configurable user preferences. It is routinely used in the 
UMC Utrecht, free available and not related to any 
commercial party.  
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Purpose/Objective: A four year old male was presented with 
prostate rhabdomyosarcoma. Radiation therapy was required. 
A multi-disciplinary team of members from three cancer 
treatment centres and a university research centre was 
assembled to deliver a treatment method using 
brachytherapy.  
Materials and Methods: A hybrid LDR/HDR technique was 
developed, whereby LDR sources (I125 seeds) were used as 
temporary implants for a delivery lasting 4 days. This 
treatment option provided lower long term morbidity, and 
better sparing of surrounding organs in comparison to a 
contemporary HDR delivery (Ir192), external beam methods or 
surgery. The treatment involved the insertion of 6F plastic 
catheters in a HDR style implant, with the use of a custom 
made paediatric insertion template, which allowed a higher 
concentration of catheters and reduced the limitations of the 
smaller pubic arch on insertion. Fusion of ultrasound and CT 
was used as the imaging modality for the construction of the 
treatment plan. I125 seeds were loaded into 4F catheters in a 
required arrangement to fulfil the plan, with the 4F catheters 
placed inside the 6F catheters to achieve the implant.  
This study outlines the approach to the many challenges that 
needed to be overcome prior to attempting to deliver this 
novel technique: I125 seeds of a higher activity than standard 
were required to deliver the prescribed dose within a four 
day treatment window. How can traditional seed implant 
software be used to calculate the delivered dose when 
calculations are performed as an extrapolation to infinite 
time? How can the dose calculations be verified 
independently? How many seeds would be required and what 
activity is needed? Could changes be made to the plan mid-
delivery if inadequacies in the coverage were discovered? 
What are the safety implications for staff loading the higher 
activity seeds and for staff in the intensive care unit, where 
the delivery was performed? 
Results: The team successfully delivered the treatment after 
fulfilling the requirements of the above challenges. 16 
catheters were inserted into the patient, with 60 seeds of 
activity 4.40mCi each used in the treatment. 100 dummy 
seeds were initially loaded into the implanted catheters for 
CT imaging, giving the ability to see all possible locations for 
planning, from which 60 locations were selected. MRI scans 
were performed on day 2, in addition to daily X-rays, to 
ensure the integrity of the plan throughout the treatment. 
One adjustment to the plan was performed on day 2 of the 
treatment, with the movement of 5 seeds from high dose to 
low dose regions. 
Conclusions: The team successfully resolved the challenges, 
despite this being a novel technique. The hybrid LDR/HDR 
brachytherapy technique was used to treat this particular 
patient. A protocol for the delivery of this technique for 
future cases is under development for use in Australian 
centres, where an appropriate team can be assembled.  
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Purpose/Objective: To systematically compare the accuracy 
of planar (MapCHECK2) and helical (ArcCHECK) diode array 
measurements for pre-treatment QA. The effectiveness of 
each device was assessed for 2D phantom dose and 3D 
patient dose verification. 
Materials and Methods: 67 sliding window IMRT plans were 
measured using ArcCHECK (AC) and MapCHECK2 (MC) diode 
arrays (Sun Nuclear Corporation, Fl, USA). All MC 
measurements were performed at gantry 0° and water 
equivalent depth of 10 cm and 100 cm SDD. AC 
measurements were performed at the planned gantry angles 
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with the AC set up as recommended by the manufacturer. All 
measurements were corrected for daily output variations. 
3DVH software (Sun Nuclear Corporation, Fl, USA) was used 
to create a measurement guided 3D dose estimation in the 
patient's planning CT. Plans were created in Eclipse TPS v11 
using AAA and DVO v11.0.30 and delivered using a Varian 21iX 
linac (Varian Medical Systems, Ca, USA). The plans included 
both 6 and 10 MV photon energies and covered a range of 
treatment sites. 
The measured and planned 2D dose distributions were 
compared using a 2%G/2mm 2D gamma pass rate (GPR). The 
3DVH and TPS 3D dose distributions were compared using a 
2%G/2mm 3D GPR and DVH analysis for the PTV and OARs. 
Results: AC and MC 2D GPRs are equivalent for plans with 
mean field area ≤ 120 cm2 (figure 1). However, after 
processing with 3DVH, calculated 3D GPRs for AC deteriorate 
significantly compared to MC, particularly for 10 MV plans. 
This is caused by the different processes involved in 
converting the AC and MC measurements to 3D dose 
distributions by 3DVH. 
For plans with a mean field area > 120 cm2 the 2D and 3D 
GPRs for AC are significantly worse than for MC. This may be 
due to the obliquity of the fields relative to the diodes at the 
edge of the array leading to shielding and directional 
dependence effects. The AC software does correct for these 
effects but our measurements suggest these corrections are 
not sufficient. Overall, MC based 3D dose estimations are in 
closer agreement with the TPS for all field sizes and 
energies. 
 
Figure 1: 2D and 3D GPR versus mean field area (cm2). 
Table 1 shows that the conversion from 2D to 3D for AC leads 
to reduced GPRs for 10 MV plans. The primary cause of this is 
a difference between the 10 MV 3DVH AC PDDs and the 
measured PDDs. In contrast, the 6 MV 3DVH AC PDDs match 
measured PDDs and the conversion to 3D improved the GPRs 
for 6 MV plans. The difference between 6 and 10 MV 3D dose 
estimation is also evident in the PTV Dmean. 
Table 1: Mean (±s) 2%/2mm GPRs and percentage variation in 
mean dose to the PTV calculated by 3DVH compared to the 
TPS. 
 
 
 
Conclusions: For IMRT QA, ArcCHECK is not an ideal system 
for plans with field area > 120 cm2. For 3D dose estimation 
using 3DVH, the ArcCHECK performed significantly worse for 
10 MV than for 6 MV plans. Overall, we found that the 
MapCHECK2 was more suitable than the ArcCHECK for 3D 
dose estimation using 3DVH. 
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Purpose/Objective: Stereotactic radiosurgery alone has 
become a popular treatment option in the management of 
patients with brain metastases. Multi- or single-isocenter 
dynamic conformal arcs (DCA) and volumetric modulated arc 
therapy (VMAT) are two common used delivery techniques. 
Recently, a dedicated inverse optimized brain metastases 
treatment planning solution using single isocenter multiple 
DCA has been developed, with intend to carefully balance 
normal tissue protection, target coverage and treatment 
speed. The purpose of the current study was to investigate 
the feasibility of this novel software and to benchmark it 
against well-established multi-isocenter DCA and single 
isocenter VMAT approaches. 
Materials and Methods: Ten previously treated patients were 
selected representing a variable number of lesions, range of 
target sizes and shapes most frequently observed in the 
practice of SRS for brain metastases. Number of lesions 
ranged between 1 and 8. The original multi-isocenter DCA 
(MIDCA) treatment plans were replanned with both single-
isocenter VMAT approach and the novel brain metastases tool 
(Elements, Brainlab AG, Germany). The treatment dose was 
20 Gy at the 80% prescription isodose. For all the plans, the 
dose to the surrounding healthy brain tissue (brainstem, 
cochlea, optical nerve, eyes and lens) was optimized to 
minimize normal tissue complications. The plans were 
evaluated by calculation of Paddick conformity and gradient 
